FSBW Insider Filing: Benjamin Crowl Receives Restricted Stock and Options
Rhea-AI Filing Summary
Benjamin Crowl, Chief Lending Officer and EVP of FS Bancorp, Inc. (FSBW), reported equity awards and option grants on 08/15/2025. He received 2,000 restricted shares under the 2018 Equity Incentive Plan, bringing his reported direct beneficial ownership to 16,789 shares after the award. He was also granted 6,000 stock options with a $40.14 exercise price and an expiration date of 08/15/2035, bringing total reported beneficial ownership of underlying shares to 27,684 shares. The restricted shares and options vest in equal 25% annual installments beginning on 08/15/2026. The Form 4 is signed by Crowl on 08/18/2025.
Positive
- Received 2,000 restricted shares under the 2018 Equity Incentive Plan, increasing direct ownership to 16,789 shares
- Granted 6,000 stock options with a clear exercise price of $40.14 and expiration 08/15/2035
- Vesting schedule defined: awards vest 25% per year beginning 08/15/2026, indicating retention alignment
Negative
- None.
Insights
TL;DR: Executive received time‑vested equity and options, modestly increasing reported ownership; impact appears routine and alignment‑focused.
The grant of 2,000 restricted shares and 6,000 options is disclosed as compensation under the 2018 Equity Incentive Plan. The awards vest 25% annually starting August 15, 2026, indicating multi‑year retention incentives rather than immediate liquidity. The option exercise price is stated at $40.14 with a 2035 expiration, and the report shows total beneficial ownership figures post‑award: 16,789 shares direct and 27,684 shares when including underlying options. For investors, this is a common executive compensation disclosure that increases insider alignment without immediate share dilution.
TL;DR: Grants follow standard equity plan structure with multi‑year vesting; disclosure is complete and timely per Section 16 filing.
The filing documents an award of restricted stock and stock options under the company’s 2018 Equity Incentive Plan with explicit vesting schedules and an exercise price for options. The Form 4 was filed and signed within a few days of the 08/15/2025 transaction, meeting reporting expectations. Vesting beginning in 2026 suggests retention intent. No departures, amendments, or related‑party caveats are disclosed in this filing.